Department of Psychiatry, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada.
Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, USA.
Mol Psychiatry. 2020 Apr;25(4):906-913. doi: 10.1038/s41380-018-0106-5. Epub 2018 Jun 19.
Identifying biomarkers in schizophrenia during the first episode without the confounding effects of treatment has been challenging. Leveraging these biomarkers to establish diagnosis and make individualized predictions of future treatment responses to antipsychotics would be of great value, but there has been limited progress. In this study, by using machine learning algorithms and the functional connections of the superior temporal cortex, we successfully identified the first-episode drug-naive (FEDN) schizophrenia patients (accuracy 78.6%) and predict their responses to antipsychotic treatment (accuracy 82.5%) at an individual level. The functional connections (FC) were derived using the mutual information and the correlations, between the blood-oxygen-level dependent signals of the superior temporal cortex and other cortical regions acquired with the resting-state functional magnetic resonance imaging. We also found that the mutual information and correlation FC was informative in identifying individual FEDN schizophrenia and prediction of treatment response, respectively. The methods and findings in this paper could provide a critical step toward individualized identification and treatment response prediction in first-episode drug-naive schizophrenia, which could complement other biomarkers in the development of precision medicine approaches for this severe mental disorder.
在没有治疗混杂效应的情况下识别首发精神分裂症中的生物标志物一直具有挑战性。利用这些生物标志物来建立诊断,并对未来抗精神病药物治疗的个体反应进行个体化预测将具有重要价值,但进展有限。在这项研究中,我们通过使用机器学习算法和优势颞叶皮层的功能连接,成功地识别了首次发作未用药的精神分裂症患者(准确率为 78.6%),并在个体水平上预测了他们对抗精神病药物治疗的反应(准确率为 82.5%)。功能连接是使用优势颞叶皮层的血氧水平依赖信号与静息状态功能磁共振成像获得的其他皮质区域之间的互信息和相关性来获得的。我们还发现,互信息和相关功能连接分别在识别个体首次发作未用药精神分裂症和预测治疗反应方面具有信息性。本文中的方法和发现可以为首次发作未用药精神分裂症的个体化识别和治疗反应预测提供关键步骤,这可以补充其他生物标志物,为这种严重精神障碍的精准医疗方法的发展做出贡献。